Amedeo Smart

Free Medical Literature Service

 

Amedeo

Colorectal Neoplasms
  Free Subscription

Articles published in
Anticancer Res
    October 2025
  1. TAKAHASHI H, Kojima D, Miyasaka Y, Wada H, et al
    Neoadjuvant Chemotherapy for Initially Resectable Metachronous Colorectal Cancer Liver Metastases Is Associated With Early Postoperative Relapse.
    Anticancer Res. 2025;45:4547-4564.
    >> Share

  2. JIMENEZ PB, Merly AA, Shekouhi R, Demirors B, et al
    Survival Impact and Sociodemographic Correlates of Colon Cancer Surgery Refusal.
    Anticancer Res. 2025;45:4305-4313.
    >> Share

  3. KANG BM, Han Q, Li S, Kim JS, et al
    Recombinant Methioninase Selectively Eliminates Cancer Cells Co-cultured With Normal Fibroblasts Indicating the High-Precision Efficacy of Targeting Methionine Addiction of Cancer.
    Anticancer Res. 2025;45:4193-4200.
    >> Share

  4. FUKATA K, Ogura A, Murata Y, Kobayashi R, et al
    The Impact of Adjuvant Chemotherapy in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemotherapy: A Propensity Score Matching Cohort Study.
    Anticancer Res. 2025;45:4431-4439.
    >> Share

  5. CIFTCI M, Ozgur E, Kulle CB, Gezer U, et al
    Exploring the Clinical Significance of Circulating H19 lncRNA and IGF-2 mRNA in Colorectal Carcinoma.
    Anticancer Res. 2025;45:4243-4251.
    >> Share

  6. HARISI R, Jaray B, Zsirka A, Kulka J, et al
    Differential PCNA Expression Between Neoplastic and Adjacent Mucosa as a Prognostic Marker in Colorectal Adenoma-Carcinoma Progression.
    Anticancer Res. 2025;45:4415-4430.
    >> Share

    September 2025
  7. WADA N, Nishida N, Takeda M, Sekido Y, et al
    Efficacy and Safety of S-1 and Oxaliplatin With Radiotherapy for Anorectal Cancer.
    Anticancer Res. 2025;45:3847-3857.
    >> Share

  8. OTANI K, Kazama K, Aoyama T, Hashimoto I, et al
    Geriatric Nutritional Risk Index Predicts Prognosis in Older Patients With Colorectal Cancer: A Multicenter Study.
    Anticancer Res. 2025;45:4015-4025.
    >> Share

  9. KOKAINE L, Daneberga Z, Satcs M, Zvina D, et al
    The Prognostic Role of microRNAs 142-5p, 182-3p, and 99a-3p in Locally Advanced Rectal Cancer Patients.
    Anticancer Res. 2025;45:3895-3912.
    >> Share

  10. KIM J, Han Q, Li S, Kang BM, et al
    Combinations of Salmonella typhimurium A1-R, Recombinant Methioninase, and Chloroquine, Each Targeting Fundamental Cancer Hallmarks, Are Selectively Effective on Colon Cancer Cells Compared to Normal Fibroblasts.
    Anticancer Res. 2025;45:3661-3668.
    >> Share

  11. NOZAWA H, Kasuga SO, Murono K, Sasaki K, et al
    Effects of Neoadjuvant Treatments on Mesorectal Computed Tomography Values and Tumor Regression in Rectal Cancer.
    Anticancer Res. 2025;45:3921-3930.
    >> Share

  12. KIMURA N, Hiraki M, Furukawa S, Ikuno H, et al
    Oncological Outcomes of Varying Resection Margin Lengths in Colon Cancer Surgery: A Retrospective Analysis.
    Anticancer Res. 2025;45:4005-4013.
    >> Share

    August 2025
  13. OGURA A, Murata Y, Sando M, Kobayashi R, et al
    Response-guided Strategy Based on Induction Chemotherapy Without Routine Use of Radiotherapy for Locally Advanced Rectal Cancer.
    Anticancer Res. 2025;45:3393-3398.
    >> Share

  14. MUKOHYAMA J, Saito I, Mochizuki S, Ota Y, et al
    Endometrial Cancer Metastatic to the Sigmoid Colon and Pelvic Retroperitoneal Space: A Case Report.
    Anticancer Res. 2025;45:3567-3573.
    >> Share

  15. LEE S, Koh JW, Lee JH, Park SJ, et al
    Silencing of Acyl-CoA Thioesterase 7 Inhibits Proliferation and Metastatic Potential in Colorectal Cancer Cells.
    Anticancer Res. 2025;45:3315-3325.
    >> Share

    July 2025
  16. HUANG CW, Yang JS, Tsai YF, Kuo SC, et al
    Anti-cancer Effects of a Novel Curcumin Derivative, 4,4-Diallyl Curcumin Bis(2,2-Hydroxymethyl)Propanoate (35e), on Radio-resistant Colorectal Cancer Cells.
    Anticancer Res. 2025;45:2891-2904.
    >> Share

  17. ASANO Y, Han Q, Li S, Mizuta K, et al
    The Combination of the Autophagy Inhibitor Chloroquine and Recombinant Methioninase Has Selective Synergistic Efficacy on Human Colon Cancer Cells But Not on Normal Human Fibroblasts.
    Anticancer Res. 2025;45:2825-2831.
    >> Share

  18. KIM J, Han Q, Kang BM, Mizuta K, et al
    The Triple Combination of Recombinant Methioninase, Rapamycin, and Chloroquine Synergistically Eradicates HCT116 Colon Cancer Cells.
    Anticancer Res. 2025;45:2773-2779.
    >> Share

  19. LEE J, Kim H, Moon J, Nualsanit T, et al
    Damnacanthal Suppresses TCF4 Expression in Colorectal Cancer Cells.
    Anticancer Res. 2025;45:2847-2858.
    >> Share

  20. KANG BM, Han Q, Li S, Mizuta K, et al
    The Conditions of Non-rescuability of Methioninase-treated Cancer Cells by Methionine Replenishment: The Point of No Return.
    Anticancer Res. 2025;45:2817-2823.
    >> Share

  21. NGUYEN MLT, Bui LA, Pham C, Nham PLT, et al
    Adiponectin Receptor Agonist Suppresses Human Colorectal Cancer.
    Anticancer Res. 2025;45:3059-3068.
    >> Share

  22. VAN BUSSEL MTJ, Bravenboer N, Essen HV, Snaebjornsson P, et al
    Bone Toxicity Case Report Combining Encorafenib, Cetuximab and WNT974 in a Phase I Trial.
    Anticancer Res. 2025;45:3137-3147.
    >> Share

  23. SUETSUGU F, Tadokoro T, Fujita K, Fujihara S, et al
    Antitumor Effects of Epigallocatechin-3-Gallate on Colorectal Cancer: An In Vitro and In Vivo Study.
    Anticancer Res. 2025;45:2937-2947.
    >> Share

    June 2025
  24. MINAMI S, Miyoshi N, Fujino S, Yasui M, et al
    Role of the Circadian Clock Gene DEC1 in Chemosensitivity and Apoptosis in Colorectal Cancer.
    Anticancer Res. 2025;45:2309-2328.
    >> Share

  25. YU X, Tsunedomi R, Hazama S, Nakagami Y, et al
    Immunogenicity of Neoantigens in Colorectal Cancer: Potential Influence of Tumor Mutation Burden, Stages, and Metastasis.
    Anticancer Res. 2025;45:2385-2399.
    >> Share

  26. ANDO Y, Orito H, Mizuno T, Katsuno H, et al
    Effect of a Biweekly Dosing Schedule on Severe Neutropenia Induced by Trifluridine/Tipiracil in Colorectal Cancer.
    Anticancer Res. 2025;45:2587-2594.
    >> Share

  27. ESKELINEN M, Selander T, Guimaraes DP, Kaarniranta K, et al
    Four Different Artificial Intelligence Models Versus Logistic Regression to Enhance the Diagnostic Accuracy of Fecal Immunochemical Test in the Detection of Colorectal Carcinoma in a Screening Setting.
    Anticancer Res. 2025;45:2477-2491.
    >> Share

  28. KODAMA H, Yamaguchi T, Kameishi S, Kadono T, et al
    Tumor Budding Grade and T Stage as Recurrence Predictors of High-risk Stage II Colorectal Cancer.
    Anticancer Res. 2025;45:2619-2628.
    >> Share

  29. KATAOKA A, Kawasaki T, Kaira K, Hirano Y, et al
    Pathological Investigation of Grasping-related Mesenteric Injury During Laparoscopic Colorectal Cancer Resection.
    Anticancer Res. 2025;45:2493-2499.
    >> Share

  30. ASANO Y, Han Q, Li S, Mizuta K, et al
    Selective Synergy of Ivermectin Combined With Recombinant Methioninase Against Colon-Cancer Cells in Contrast to Normal Fibroblasts.
    Anticancer Res. 2025;45:2257-2263.
    >> Share

  31. KOBAYASHI Y, Takano Y, Matsukida S, Takishima T, et al
    Prognostic Nutritional Index Is the Key Prognostic Factor in Elderly Patients With Colorectal Cancer.
    Anticancer Res. 2025;45:2595-2603.
    >> Share

    May 2025
  32. HWANG HH, Yoo JS, Je JH, Lee HC, et al
    SH003 Inhibits Proliferation and Induces Apoptosis in Colon Cancer Through the RTK-STAT3 Pathway.
    Anticancer Res. 2025;45:1965-1980.
    >> Share

  33. IZUTANI Y, Ogino T, Fujii M, Sekido Y, et al
    Appendectomy Mitigates Ulcerative Colitis Activity and Delays Colorectal Cancer Onset: A Retrospective Cohort Study.
    Anticancer Res. 2025;45:2205-2214.
    >> Share

    April 2025
  34. OKEMOTO D, Yamaguchi T, Sugino K, Matsuo N, et al
    Chemotherapy Efficacy in Patients With Colorectal Cancer Experiencing Early Recurrence During or After Adjuvant Chemotherapy.
    Anticancer Res. 2025;45:1695-1705.
    >> Share

  35. YUEH TC, Chen YJ, Mong MC, Ke TW, et al
    The Contribution of Interleukin-12A and Interleukin-12B Genotypes to Colorectal Cancer in Taiwan.
    Anticancer Res. 2025;45:1501-1512.
    >> Share

  36. NII T, Yoshimi T, Tanito K, Hijii S, et al
    Inflammation-triggering Engineered Macrophages (MacTriggers) Are Promising Cell-based Therapeutic Avenues for Chemoresistant Solid Tumors.
    Anticancer Res. 2025;45:1395-1405.
    >> Share

  37. SUGIMOTO K, Irie T, Momose H, Kochi S, et al
    Circulating Tumor DNA Methylation Is a Biomarker of Poor Recurrence-free Survival in Locally-Advanced Rectal Cancer.
    Anticancer Res. 2025;45:1559-1573.
    >> Share

    March 2025
  38. TERAISHI F, Yoshida Y, Shoji R, Kanaya N, et al
    Short-term Safety of Robot-assisted Rectal Surgery in Patients Aged >/=75 Years: A Single-center Retrospective Study.
    Anticancer Res. 2025;45:1291-1299.
    >> Share

  39. WEISS TS, Buechler C
    Proprotein Convertase Subtilisin/Kexin Type 9 Induction in Hypercholesterinemic Patients With Primary and Metastatic Liver Tumors.
    Anticancer Res. 2025;45:1171-1180.
    >> Share

  40. SHOJI R, Teraishi F, Kondo Y, Yoshida Y, et al
    Tailoring Neoadjuvant Therapy for Rectal Cancer: A Single-center Study of Local Recurrence Patterns.
    Anticancer Res. 2025;45:1261-1271.
    >> Share

  41. GOTO K, Ryu S, Imaizumi Y, Iwauchi S, et al
    Urethral Visualization Using Near-infrared Light Observation During Transanal/Perineal Total Mesorectal Excision.
    Anticancer Res. 2025;45:1241-1249.
    >> Share

  42. SUGIYAMA M, Kasagi Y, Yokomizo R, Terashi M, et al
    Oncologic Relevance and Anal Preservation Potential of Transanal Total Mesorectal Excision for Rectal Cancer Invading Adjacent Organs.
    Anticancer Res. 2025;45:1233-1239.
    >> Share

    February 2025
  43. DREVS J, Malhotra MS, Sahinbas H, Iliopoulos A, et al
    Adjusting Treatment Strategies Using Circulating Tumor Cells: Preliminary Results on Metastatic Colorectal Cancer.
    Anticancer Res. 2025;45:491-502.
    >> Share

  44. YANG IJ, Kim DH, Lee KH, Kim JY, et al
    Safety and Survival Benefit of Adjuvant Chemotherapy for Elderly Patients With Stage II/III Colon Cancer.
    Anticancer Res. 2025;45:797-809.
    >> Share

  45. TAKISHIMA T, Kobayashi Y, Matsukida S, Kai W, et al
    Negative Impact of Low Serum Cholinesterase on Short- and Long-term Outcomes in Elderly Patients Undergoing Scheduled Surgery for Colorectal Cancer.
    Anticancer Res. 2025;45:743-750.
    >> Share

    January 2025
  46. KAWAMURA H, Imaizumi T, Miyakawa T, Nakao E, et al
    Development of a Prognostic Model for Stage IV Colorectal Cancer Using Metastatic Patterns.
    Anticancer Res. 2025;45:341-350.
    >> Share

  47. ZHANG Y, Li X, Li S, Yang Z, et al
    Alternating Oxaliplatin and Irinotecan Chemotherapy Combined With Capecitabine and Bevacizumab for Microsatellite-stable Stage IV Metastatic Colon Cancer With a BRAF V600E Mutation: Two Case Reports Indicating Survival Improvement over Standard Therap
    Anticancer Res. 2025;45:399-404.
    >> Share

  48. KASUGA SO, Nozawa H, Ishihara S
    Changes in Mesorectal CT Values and Therapeutic Effect of Preoperative Chemoradiotherapy in Rectal Cancer.
    Anticancer Res. 2025;45:359-367.
    >> Share

  49. ESKELINEN M, Selander T, Guimaraes DP, Kaarniranta K, et al
    Artificial Intelligence Models Could Enhance the Diagnostic Accuracy (DA) of Fecal Immunochemical Test (FIT) in the Detection of Colorectal Adenoma in a Screening Setting.
    Anticancer Res. 2025;45:267-275.
    >> Share

  50. TSAI YY, Ke TW, Huang CH, Chen TW, et al
    Prognostic Relevance of Immunosuppressive CD155/TIGIT Signaling in Locally Advanced Rectal Cancer Patients With Neoadjuvant Chemoradiotherapy.
    Anticancer Res. 2025;45:323-333.
    >> Share

    December 2024
  51. KIM HB, Choi WY, Kim SH, Lee HJ, et al
    GNAO1: A Novel Tumor Suppressor Gene in Colorectal Cancer Pathogenesis.
    Anticancer Res. 2024;44:5425-5433.
    >> Share

  52. SHIBUTANI M, Kashiwagi S, Tanda H, Seki Y, et al
    Prognostic Significance of Innovative Inflammation-nutrition Biomarker Score in Patients With Colorectal Cancer.
    Anticancer Res. 2024;44:5559-5567.
    >> Share

  53. SHIN H, Kim Y, Lee Y, Kim J, et al
    Chlorhexidine Dihydrochloride Shows Anti-tumor Effects in Desmoid Tumors and Colorectal Cancer.
    Anticancer Res. 2024;44:5435-5443.
    >> Share

  54. LEE Y, Kim Y, Shin H, Ryu YC, et al
    Anti-tumor Effects of Idarubicin Hydrochloride in Desmoid Tumors.
    Anticancer Res. 2024;44:5313-5322.
    >> Share

    November 2024
  55. ZADOROZNYJ A, Karam E, Michot N, Thiery J, et al
    Clinical and Oncological Impact of a Protective Ileostomy in Rectal Cancer Patients Undergoing Adjuvant Chemotherapy.
    Anticancer Res. 2024;44:4995-5005.
    >> Share

  56. NGUYEN MLT, Pham C, Nguyen TS, Nham PLT, et al
    Single-agent Adavosertib Shows Anticancer Effects Against Colorectal Cancer Cells.
    Anticancer Res. 2024;44:4941-4949.
    >> Share

  57. YASUI C, Kono Y, Ishiguro R, Yagyu T, et al
    New Treatment Modalities for Colorectal Cancer Through Simultaneous Suppression of FSP1 and GPX4.
    Anticancer Res. 2024;44:4905-4914.
    >> Share

  58. SUNG YN, Kim Y, Datuin AT, Jang I, et al
    Routine Elastic Staining Helps Detection of Vascular Invasion in Colorectal Cancer: A Comprehensive Analysis of T3 or Higher Tumors Without Lymph Node Metastasis.
    Anticancer Res. 2024;44:5059-5065.
    >> Share

    October 2024
  59. UNRUG-BIELAWSKA K, Earnshaw D, Cybulska-Lubak M, Kaniuga E, et al
    Therapeutic Responses to Two New SN-38 Derivatives in Colorectal Cancer Patient-Derived Xenografts and Respective 3D In Vitro Cultures.
    Anticancer Res. 2024;44:4219-4224.
    >> Share

  60. RUBIO CA, Vieth M, Lang-Schwarz C
    Nondysplastic Colon Crypts Intercalated in Tubular Adenomas Support Field Cancerization.
    Anticancer Res. 2024;44:4371-4377.
    >> Share

  61. HOSIK J, Hosikova B, Kolarova H, Bajgar R, et al
    5,10,15,20-Tetrakis(4-sulfonatophenyl)porphyrin Zinc and Chloro-aluminum Phthalocyanine Disulfonate in Photodynamic Therapy of Colorectal Adenocarcinoma In Vitro.
    Anticancer Res. 2024;44:4339-4346.
    >> Share

  62. VIRGILIO E, Salvemini C, Treglia MG, Thai E, et al
    Hotspots of Anal Cancer Screening in a High-risk Population: A Clinical Study on Free Provision, Best Method, Self-sampling, and Independent Risk Factors.
    Anticancer Res. 2024;44:4465-4481.
    >> Share

    September 2024
  63. HOSOKAWA A, Tamura H, Ichihara A, Imamura N, et al
    Pathological Complete Response to Liver Metastasis With Pembrolizumab in a Previously Treated Patient With Microsatellite Instability-high Colorectal Cancer.
    Anticancer Res. 2024;44:4119-4125.
    >> Share

  64. SHIRAISHI T, Yamaguchi A, Shibasaki Y, Osone K, et al
    Risk Factors of Poor Outcomes After Colorectal Cancer Surgery for Patients With Severe Comorbidities.
    Anticancer Res. 2024;44:4073-4083.
    >> Share

  65. COZZANI F, Ricchiuto M, Virgilio E, Viani L, et al
    The Controlling Nutritional Status (CONUT) Score Predicts Post-operatory Risks and Prognosis in Patients With Surgically Treated Colon Cancer: A Retrospective Study.
    Anticancer Res. 2024;44:3955-3964.
    >> Share

  66. JINNO T, Yamaguchi J, Ogura A, Kokuryo T, et al
    Loss of Trefoil Factor 1 Accelerates the Immune Response to Colorectal Cancer.
    Anticancer Res. 2024;44:3757-3769.
    >> Share

  67. FUKUSHIMA G, Sato E, Udo R, Tago T, et al
    Stromal CD4 (+) T Cell Subsets Mediate Antitumor Cytotoxic Immune Responses in Human Colorectal Carcinoma.
    Anticancer Res. 2024;44:3899-3906.
    >> Share

  68. KAYANO H, Mamuro N, Kamei Y, Ogimi T, et al
    Risk Factors Associated With Perioperative Skeletal Muscle Loss in Patients With Colorectal Cancer.
    Anticancer Res. 2024;44:4019-4029.
    >> Share

  69. TAKEDA K, Kikuchi Y, Sawada YU, Kumamoto T, et al
    Simultaneously Detected Liver and Lung Metastases from Colorectal Carcinoma: A Potential Treatment Strategy.
    Anticancer Res. 2024;44:3945-3954.
    >> Share

    August 2024
  70. KAMADA T, Furukawa K, Takahashi J, Aida T, et al
    Preoperative Vertebral Fracture: A Prognostic Factor in Stage I-III Colorectal Cancer.
    Anticancer Res. 2024;44:3533-3541.
    >> Share

  71. YOKOTA Y, Nozawa H, Sonoda H, Yokoyama Y, et al
    Indoleamine 2,3-Dioxygenase Inhibitor Suppresses Colon Cancer Cell Migration, Invasion, and Epithelial-Mesenchymal Transition.
    Anticancer Res. 2024;44:3337-3342.
    >> Share

  72. TSUJIO G, Fukuoka T, Sugimoto A, Yonemitsu K, et al
    The Efficacy of Chemical Bowel Preparation Against Incisional Surgical Site Infection in Colorectal Cancer Surgery: A Propensity Score Matching Study.
    Anticancer Res. 2024;44:3473-3480.
    >> Share

  73. FUKUDA J, Sudo T, Kikuchi M, Kawahara A, et al
    Identification of DNA Repair-related Genes as Biomarkers Reflecting MSI, TMB, and TIL in Colorectal Cancer.
    Anticancer Res. 2024;44:3567-3575.
    >> Share

  74. TAKAHASHI H, Kojima D, Wada H, Hanaoka K, et al
    A Bridge to Curative Surgery for Obstructive Colorectal Cancer: Self-expandable Metallic Stent Versus Decompression Tube.
    Anticancer Res. 2024;44:3427-3441.
    >> Share

  75. MUKOHYAMA J, Koizumi M, Yamashita K, Yoshimi A, et al
    Knockdown of CDX2 Induces microRNA-221 Up-regulation in Human Colon Cancer Cells.
    Anticancer Res. 2024;44:3553-3556.
    >> Share

    July 2024
  76. KOMORI K, Yoshida M, Tsukushi S, Kinoshita T, et al
    Combined Pubic Arch and Ischial Bone Resection for Metachronous and Frequent Local Recurrences of Rectal Cancer.
    Anticancer Res. 2024;44:3205-3211.
    >> Share

  77. LEE SH, Kim SA, Park SJ, Lee MY, et al
    NUAK2 Inhibitors, KHKI-01128 and KHKI-01215, Exhibit Potent Anticancer Activity Against SW480 Colorectal Cancer Cells.
    Anticancer Res. 2024;44:2909-2919.
    >> Share

  78. SHIOI I, Ogawa H, Naito R, Endo M, et al
    Risks and Outcomes of Early Dose Reduction in Adjuvant CAPOX Therapy for Colorectal Cancer.
    Anticancer Res. 2024;44:3013-3023.
    >> Share

  79. TSUMURAYA H, Mimura K, Nakajima S, Hanayama H, et al
    Tumor Infiltrating Effector Regulatory T Cells Express VEGF Receptor 2 in Patients With Colorectal Cancer.
    Anticancer Res. 2024;44:2933-2941.
    >> Share

  80. KARLIKOVA M, Curillova M, Pecen L, Karnos V Jr, et al
    Evaluation of Serum Cytokeratines, Thymidine Kinase, and Growth Factors as Cancer Biomarkers in Colorectal Cancer.
    Anticancer Res. 2024;44:3105-3113.
    >> Share

    June 2024
  81. MOON SU, Lee JH, Shah M, Yoon S, et al
    RRM2 Is a CTNNB1 Transport Regulator Promoting Colon Cancer Progression.
    Anticancer Res. 2024;44:2471-2485.
    >> Share

  82. TOREN W, Sasor A, Ansari D, Andersson R, et al
    ARHGAP4 as a Prognostic Biomarker for Colon Liver Metastases After Surgical Resection.
    Anticancer Res. 2024;44:2597-2604.
    >> Share

  83. MATSUDA A, Yamada T, Takahashi G, Matsumoto S, et al
    Significance of Adjuvant Chemotherapy for Obstructive Colorectal Cancer After Stent Placement: A Multicenter Retrospective Study.
    Anticancer Res. 2024;44:2737-2745.
    >> Share

  84. LIM SC, Lee TB, Han SI
    Caffeic Acid Enhances Anticancer Drug-induced Apoptosis in Acid-adapted HCT116 Colon Cancer Cells.
    Anticancer Res. 2024;44:2587-2595.
    >> Share

    May 2024
  85. WAGNER D, Karitnig R, Wienerroither V, Hau HM, et al
    Sarcopenic Obesity Promotes Recurrence in Patients Undergoing Resection for Colorectal Liver Metastases (CRLM).
    Anticancer Res. 2024;44:2177-2183.
    >> Share

    April 2024
  86. WU CC, Su CC, Chen YH, Hsu CW, et al
    Comparative Effectiveness of Adjuvant Therapy on Survival in Patients With Metastatic Colorectal Cancer.
    Anticancer Res. 2024;44:1619-1628.
    >> Share

  87. TANAKA H, Hayashi H, Tomita H, Tokumaru Y, et al
    Association of Preoperative and Postoperative Plasma Syndecan-1 and Colorectal Cancer Outcome.
    Anticancer Res. 2024;44:1611-1618.
    >> Share

  88. SHIRAISHI T, Tominaga T, Ono R, Noda K, et al
    Short- and Long-term Outcomes After Colonic Stent Insertion as a Bridge to Surgery in Elderly Colorectal Cancer Patients.
    Anticancer Res. 2024;44:1637-1643.
    >> Share

  89. SYRJANEN K, Eskelinen M, Meklin J, Hendolin P, et al
    Colorectal Cancer Screening by Fecal Immunochemical Tests (FIT): Considerations on Sampling and Markers (Hb and Hb/Hp Complex) of Fecal Occult Blood (FOB).
    Anticancer Res. 2024;44:1513-1523.
    >> Share

  90. BEPPU T, Yamamura K, Masuda T, Miyamoto H, et al
    High-risk Patients With Colorectal Liver Metastases Assessed by the Beppu Score Can Have Excellent Survival Through Multidisciplinary Treatment Including Local Ablation.
    Anticancer Res. 2024;44:1533-1539.
    >> Share

  91. SATOYOSHI T, Hirohashi Y, Okuya K, Miyo M, et al
    CD8-positive T Cell Infiltration With Human Leukocyte Antigen Class 1 Expression Predicts Patients With Stage IV Colorectal Cancer Survival.
    Anticancer Res. 2024;44:1603-1610.
    >> Share

  92. AOYAMA T, Yukawa N, Saito A
    Clinical Impact of Nutrition and Inflammation Assessment Tools in Colorectal Cancer Treatment.
    Anticancer Res. 2024;44:1335-1351.
    >> Share

    March 2024
  93. ZHENG W, Chen K, Lv Y, Lao W, et al
    Pyrvinium Pamoate Induces Cell Apoptosis and Autophagy in Colorectal Cancer.
    Anticancer Res. 2024;44:1193-1199.
    >> Share

  94. EBATA Y, Nakanishi R, Tanaka Y, Kawazoe T, et al
    Neoadjuvant Chemotherapy in Patients With T4b or Obstructive Colon Cancer: A Single Center Retrospective Cohort Study.
    Anticancer Res. 2024;44:1281-1287.
    >> Share

  95. HARA S, Sakai D, Ikemura K, Shintani T, et al
    Comparative Efficacy and Safety of Standard and Biweekly Trifluridine/Tipiracil Regimen in Patients With Colorectal Cancer.
    Anticancer Res. 2024;44:1219-1226.
    >> Share

  96. SILVA EF, Fernandes BN, Marinello P, Deminice R, et al
    Pre and Post-high-intensity Interval Training Delays Colon Tumor Onset in a Syngeneic Mouse Model.
    Anticancer Res. 2024;44:1209-1217.
    >> Share

  97. HEGEDUS D, Szemeredi N, Gabor M, Sas J, et al
    Cyclic Amines Coupled to Indole Derivatives With Improved Efflux Pump Inhibiting Activity in Bacteria and Cancer Cells.
    Anticancer Res. 2024;44:1149-1160.
    >> Share

  98. ARDJMAND D, Kubota Y, Sato M, Han Q, et al
    Selective Synergy of Rapamycin Combined With Methioninase on Cancer Cells Compared to Normal Cells.
    Anticancer Res. 2024;44:929-933.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016